DrugPatentWatch Database Preview
Certolizumab pegol - Biologic Drug Details
Summary for certolizumab pegol
| Tradenames: | 1 |
| Patents: | 56 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for certolizumab pegol
| Mechanism of Action | Tumor Necrosis Factor Receptor Blocking Activity |
US Patents for certolizumab pegol
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | ➤ Sign Up | Knopp Biosciences LLC (Pittsburgh, PA) | ➤ Sign Up | RX | search | |
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | ➤ Sign Up | Agency for Science, Technology and Research (Singapore, SG) | ➤ Sign Up | RX | search | |
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | ➤ Sign Up | Nestec S.A. (Vevey, CH) | ➤ Sign Up | RX | search | |
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | ➤ Sign Up | Medarex, Inc. (Princeton, NJ) | ➤ Sign Up | RX | search | |
| Ucb Inc | CIMZIA | certolizumab pegol | INJECTABLE; INJECTION | 125160 | 001 | 2008-04-22 | ➤ Sign Up | Tobinick; Edward Lewis (Los Angeles, CA) | ➤ Sign Up | RX | search | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for certolizumab pegol
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2012502038 | ➤ Sign Up |
| Japan | 2015522526 | ➤ Sign Up |
| Israel | 204066 | ➤ Sign Up |
| Brazil | PI0406574 | ➤ Sign Up |
| South Korea | 20160107304 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
